Key facts
- It has raised $150K; the latest was Angel (individual) ($150K) in Jun 2025.
- SVRN Enterprises has filed 2 Form Ds with the SEC since 2024, most recently Jun 2025 ($150K sold to 1 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for SVRN Enterprises
- ·The full record, as it builds
Funding rounds
No funding rounds for SVRN Enterprises are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SVRN Enterprises
Provider of value return services intended to empower biotech innovators to fast-track scientific breakthroughs. The company addresses the disparity between the growing productivity of biomedical research and development and the diminishing efficiency of the financial and commercial infrastructure supporting biomedical innovation, enabling people to find solutions to accelerate and protect the return of value created by the innovation ecosystem, propelling scientific progress aligned to public interest and needs.
- Sector
- Business Products and Services (B2B)
- HQ
- New York, NY, United States
- Founded
- 2024
- Employees
- 2
- Website
- svrnenterprises.com/
- Ownership
- Privately Held (backing)
SVRN Enterprises doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SVRN Enterprises shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SVRN Enterprises in its N-PORT filings yet. We sweep new filings monthly.